Show Notes
At the 2026 American Society of Clinical Oncology Annual Meeting poster session, we asked four scientists to discuss their research.
Listen to the episode to hear:
Peter Stanfield, of the University of Wisconsin, explains his research on cancer screening rates in transgender and gender-diverse people.
Nico Gotera, of the University of Texas Health Science Center, explains research on GLP-1 medicines and rates of breast cancer in postmenopausal women.
Anna Tanasijevic, of the Dana-Farber Cancer Institute, explains research on how much cancer survivors exercise.
Xianghui Zou, of NYU Langone Health, explains research on the timing of immunotherapy infusions for people with early-stage triple-negative breast cancer.
More from Breastcancer.org Podcast
Actress Miranda McKeon was diagnosed with stage III breast cancer at age 19, just as she was starting her sophomore year of college. She talks about her experiences with diagnosis and treatment, as well as how she balanced presenting herself to her peers in a way that felt authentic when she was living an experience that was completely foreign to her.
Julia Maués didn’t decide to become an advocate, but her passion for patients learning science and scientists learning patient experiences propelled her to talk about her experiences.
Eleonora Teplinsky’s oncology practice has focused on people with breast cancer for more than a decade. Her new book, Beyond the Pink: Navigating Life, Health, and Breast Cancer, explains breast cancer risks, screening, diagnosis, and treatment, as well as topics that may not be discussed by all doctors.
Dr. Luba Perry is the founder and CEO of ReConstruct Bio, where she’s working to develop bioengineered living tissue implants made from a person’s own cells that then integrate with the body as living tissue. The first goal is to develop natural implants for breast reconstruction.
An advocate and communications expert with more than 20 years experience in international corporate marketing, Christina Wilhelm wrote It’s Breast Cancer, Now What? as a manual to help people navigate breast cancer treatment, return-to-work, and long-term follow-up care decisions.